Steve joined the University of Worcester in 2013, following 5 years post-doctoral experience at Cardiff University, School of Medicine (Section of Haematology), working with Professors Tonks and Darley. During his time at Cardiff, Steve investigated the role of the immune checkpoint molecule, CD200, in a type of blood cancer known as acute myeloid leukaemia (AML).
Since joining us, Steve has introduced several new modules to the Biological and Biomedical Sciences curriculum that align with his expertise, including: Immunology and Biochemistry of Cancer.
Steve has also helped to establish and lead the Worcester Biomedical Research Group, where the research focuses on Cancer, Neurodegeneration and Cardiovascular Disease.